×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

PROGRAMME:

Modérateurs: Fabrice Lécuru et Manuel Rodrigues
19:00
Spécificités des soins de support en ovaire : gestion de la carcinose symptomatique et pré-habilitation en néoadjuvant
Carole Bouleuc
 
 
19:15
Quel avenir à l’immunothérapie dans les cancers de l’ovaire ?
Audrey Bellesoeur
 
19:30
Traitement des récidives sous PARPi
Manuel Rodrigues
 
19:45
Chirurgie de la récidive : au-delà des essais GOG213, SOC1 & DESKTOP
Fabrice Lécuru
 
 
20:00
Débat/Discussion - Réponses aux questions
 
 
  
Shooting date : 2022-03-22
Last update : 2022-03-24
1 comment
Join the Discussion
  • johanne L. bonjour comment fait-on pour s inscrire ?

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Tuesday, April 15th 2025 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, April 15th 2025 from 06am to 07:30am (GMT+2)
    San Francisco : Tuesday, April 15th 2025 from 09am to 10:30am (GMT+2)
    New York : Tuesday, April 15th 2025 from 12pm to 01:30pm (GMT+2)
    Buenos Aires : Tuesday, April 15th 2025 from 01pm to 02:30pm (GMT+2)
    Reykjavik : Tuesday, April 15th 2025 from 04pm to 05:30pm (GMT+2)
    London / Dublin : Tuesday, April 15th 2025 from 05pm to 06:30pm (GMT+2)
    Paris / Berlin : Tuesday, April 15th 2025 from 06pm to 07:30pm (GMT+2)
    Istanbul : Tuesday, April 15th 2025 from 07pm to 08:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, April 15th 2025 from 08pm to 09:30pm (GMT+2)
    Bangkok : Tuesday, April 15th 2025 from 11pm to 12:30am (GMT+2)
    Shanghai : Wednesday, April 16th 2025 from 12am to 01:30am (GMT+2)
    Tokyo : Wednesday, April 16th 2025 from 01am to 02:30am (GMT+2)
    Sydney : Wednesday, April 16th 2025 from 03am to 04:30am (GMT+2)
    Wellington : Wednesday, April 16th 2025 from 05am to 06:30am (GMT+2)

    Outils utiles aux cliniciens durant la chimio néoadjuvante des cancers de l’ovaire

    Share
    Tuesday, October 18th 2022 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, October 18th 2022 from 06am to 07:30am (GMT+2)
    San Francisco : Tuesday, October 18th 2022 from 09am to 10:30am (GMT+2)
    New York : Tuesday, October 18th 2022 from 12pm to 01:30pm (GMT+2)
    Buenos Aires : Tuesday, October 18th 2022 from 01pm to 02:30pm (GMT+2)
    Reykjavik : Tuesday, October 18th 2022 from 04pm to 05:30pm (GMT+2)
    London / Dublin : Tuesday, October 18th 2022 from 05pm to 06:30pm (GMT+2)
    Paris / Berlin : Tuesday, October 18th 2022 from 06pm to 07:30pm (GMT+2)
    Istanbul : Tuesday, October 18th 2022 from 07pm to 08:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, October 18th 2022 from 08pm to 09:30pm (GMT+2)
    Bangkok : Tuesday, October 18th 2022 from 11pm to 12:30am (GMT+2)
    Shanghai : Wednesday, October 19th 2022 from 12am to 01:30am (GMT+2)
    Tokyo : Wednesday, October 19th 2022 from 01am to 02:30am (GMT+2)
    Sydney : Wednesday, October 19th 2022 from 03am to 04:30am (GMT+2)
    Wellington : Wednesday, October 19th 2022 from 05am to 06:30am (GMT+2)

    Evolution de la chirurgie du cancer de l’ovaire en 2022

    Share
    Tuesday, November 15th 2022 from 06pm to 07:30pm (GMT+1)
    Honolulu : Tuesday, November 15th 2022 from 06am to 07:30am (GMT+1)
    San Francisco : Tuesday, November 15th 2022 from 08am to 09:30am (GMT+1)
    New York : Tuesday, November 15th 2022 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Tuesday, November 15th 2022 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Tuesday, November 15th 2022 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Tuesday, November 15th 2022 from 05pm to 06:30pm (GMT+1)
    Istanbul : Tuesday, November 15th 2022 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Tuesday, November 15th 2022 from 08pm to 09:30pm (GMT+1)
    Bangkok : Tuesday, November 15th 2022 from 11pm to 12:30am (GMT+1)
    Shanghai : Wednesday, November 16th 2022 from 12am to 01:30am (GMT+1)
    Tokyo : Wednesday, November 16th 2022 from 01am to 02:30am (GMT+1)
    Sydney : Wednesday, November 16th 2022 from 02am to 03:30am (GMT+1)
    Wellington : Wednesday, November 16th 2022 from 04am to 05:30am (GMT+1)

    Spécificités des soins de support dans le cancer de l'ovaire

    Share
    Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, September 19th 2023 from 06am to 07:30am (GMT+2)
    San Francisco : Tuesday, September 19th 2023 from 09am to 10:30am (GMT+2)
    New York : Tuesday, September 19th 2023 from 12pm to 01:30pm (GMT+2)
    Buenos Aires : Tuesday, September 19th 2023 from 01pm to 02:30pm (GMT+2)
    Reykjavik : Tuesday, September 19th 2023 from 04pm to 05:30pm (GMT+2)
    London / Dublin : Tuesday, September 19th 2023 from 05pm to 06:30pm (GMT+2)
    Paris / Berlin : Tuesday, September 19th 2023 from 06pm to 07:30pm (GMT+2)
    Istanbul : Tuesday, September 19th 2023 from 07pm to 08:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, September 19th 2023 from 08pm to 09:30pm (GMT+2)
    Bangkok : Tuesday, September 19th 2023 from 11pm to 12:30am (GMT+2)
    Shanghai : Wednesday, September 20th 2023 from 12am to 01:30am (GMT+2)
    Tokyo : Wednesday, September 20th 2023 from 01am to 02:30am (GMT+2)
    Sydney : Wednesday, September 20th 2023 from 03am to 04:30am (GMT+2)
    Wellington : Wednesday, September 20th 2023 from 05am to 06:30am (GMT+2)

    Prise en charge des carcinomes séreux de bas grade en 2023

    Share
    Scroll Up